(BKIE) BNY Mellon International - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US09661T4040 • Foreign Large Blend

BKIE: Equity Securities, Depositary Receipts, Etf, Derivatives

BNY Mellon International Equity ETF (BKIE) is an exchange-traded fund that tracks the Solactive GBS Developed Markets ex United States Large & Mid Cap USD Index NTR, providing investors with exposure to large- and mid-capitalization companies in developed markets outside the United States. The fund achieves this exposure through a combination of equity securities, depositary receipts, ETFs, and derivatives that replicate the indexs performance.

The underlying index is a market capitalization-weighted index, meaning that the largest companies in the index have a greater influence on its performance. This index is designed to capture the performance of established companies in developed markets, excluding the US. As a non-diversified fund, BKIEs portfolio is heavily reliant on the performance of its constituent securities, which may increase the risk associated with investing in this ETF.

From a technical analysis perspective, BKIEs price is currently above its 20-day, 50-day, and 200-day simple moving averages (SMA20, SMA50, and SMA200), indicating a bullish trend. The Average True Range (ATR) is 1.67, representing 2.07% of the current price, suggesting moderate volatility. Given the current price of 80.97 and the 52-week high and low of 81.50 and 69.01, respectively, the ETF appears to be near its 52-week high, potentially indicating a strong uptrend.

Considering the funds Assets Under Management (AUM) of $607.16 million, BKIE has a reasonable size, which can contribute to liquidity. By analyzing the technical and fundamental data, a forecast for BKIE could be made. If the current uptrend continues, and the SMA20 and SMA50 remain supportive, the ETF may test its 52-week high at 81.50. A break above this level could lead to further gains, potentially targeting the next resistance level around 85.00. However, a decline below the SMA50 at 77.51 could signal a reversal, potentially leading to a retest of the SMA200 at 75.40.

Additional Sources for BKIE ETF

BKIE ETF Overview

Market Cap in USD 607m
Category Foreign Large Blend
TER 0.04%
IPO / Inception 2020-04-22

BKIE ETF Ratings

Growth Rating 64.2
Fundamental -
Dividend Rating 63.2
Rel. Strength -0.78
Analysts -
Fair Price Momentum 79.82 USD
Fair Price DCF -

BKIE Dividends

Dividend Yield 12m 2.85%
Yield on Cost 5y 5.06%
Annual Growth 5y 19.08%
Payout Consistency 98.6%

BKIE Growth Ratios

Growth Correlation 3m 34.5%
Growth Correlation 12m 51%
Growth Correlation 5y 72.3%
CAGR 5y 13.10%
CAGR/Max DD 5y 0.46
Sharpe Ratio 12m 1.47
Alpha 0.11
Beta 0.770
Volatility 17.62%
Current Volume 20.1k
Average Volume 20d 17.1k
What is the price of BKIE stocks?
As of May 14, 2025, the stock is trading at USD 81.74 with a total of 20,105 shares traded.
Over the past week, the price has changed by +0.50%, over one month by +8.48%, over three months by +5.42% and over the past year by +11.92%.
Is BNY Mellon International a good stock to buy?
Yes. Based on ValueRay Analyses, BNY Mellon International (NYSE ARCA:BKIE) is currently (May 2025) a good stock to buy. It has a ValueRay Growth Rating of 64.15 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BKIE as of May 2025 is 79.82. This means that BKIE is currently overvalued and has a potential downside of -2.35%.
Is BKIE a buy, sell or hold?
BNY Mellon International has no consensus analysts rating.
What are the forecast for BKIE stock price target?
According to ValueRays Forecast Model, BKIE BNY Mellon International will be worth about 91.6 in May 2026. The stock is currently trading at 81.74. This means that the stock has a potential upside of +12.01%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 91.6 12%